• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因扩增作为癌症化疗的靶点。

Gene amplification as a target for cancer chemotherapy.

作者信息

Snapka R M

机构信息

Department of Radiology, Ohio State University, Columbus 43210.

出版信息

Oncol Res. 1992;4(4-5):145-50.

PMID:1504374
Abstract

Facile gene amplification is one aspect of the genetic instability associated with transformed cells. Amplification of oncogenes and proto-oncogenes contributes to carcinogenesis and tumor progression. Gene amplification is also a common basis for resistance to anticancer drugs. The observation that low level cytotoxic stress can cause rapid loss of amplified genes from cultured cell populations suggests that gene amplification may be a potential target for cancer chemotherapy. Drug-induced loss of amplified genes is seen with a wide variety of extrachromosomally amplified genes, including drug resistance genes and proto-oncogenes. A number of drugs and differentiating agents have been reported to cause rapid loss of unstably amplified genes. An effect on amplified genes or cells carrying amplified genes may contribute to the selective action of drugs presently used for cancer chemotherapy. A better understanding of drug-induced amplified gene loss may lead to new strategies for cancer treatment.

摘要

便捷的基因扩增是与转化细胞相关的遗传不稳定性的一个方面。癌基因和原癌基因的扩增有助于致癌作用和肿瘤进展。基因扩增也是抗癌药物耐药性的常见基础。低水平细胞毒性应激可导致培养细胞群体中扩增基因快速丢失这一观察结果表明,基因扩增可能是癌症化疗的一个潜在靶点。多种染色体外扩增基因,包括耐药基因和原癌基因,都可见药物诱导的扩增基因丢失。据报道,许多药物和分化剂可导致不稳定扩增基因快速丢失。对扩增基因或携带扩增基因的细胞的影响可能有助于目前用于癌症化疗的药物的选择性作用。更好地理解药物诱导的扩增基因丢失可能会带来癌症治疗的新策略。

相似文献

1
Gene amplification as a target for cancer chemotherapy.基因扩增作为癌症化疗的靶点。
Oncol Res. 1992;4(4-5):145-50.
2
Amplification of oncogenes in human cancer cells.
Bioessays. 1998 Jun;20(6):473-9. doi: 10.1002/(SICI)1521-1878(199806)20:6<473::AID-BIES5>3.0.CO;2-N.
3
Molecular interrelationships in multidrug resistance (review).多药耐药中的分子相互关系(综述)
Anticancer Res. 1994 Mar-Apr;14(2A):433-5.
4
Fractionated ionizing radiation accelerates loss of amplified MDR1 genes harbored by extrachromosomal DNA in tumor cells.分次电离辐射加速肿瘤细胞中染色体外DNA所携带的扩增MDR1基因的丢失。
Cancer Res. 1998 Sep 1;58(17):3845-54.
5
The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).人乳腺癌细胞系SW 613-S:一个用于研究与c-myc扩增、生长因子产生及其他标志物相关的肿瘤异质性的实验系统(综述)
Anticancer Res. 1989 Sep-Oct;9(5):1265-79.
6
[Chromosomes and drug resistance of tumors].[肿瘤的染色体与耐药性]
Eksp Onkol. 1984;6(2):14-9.
7
Molecular mechanism of multidrug resistance in tumor cells.肿瘤细胞多药耐药的分子机制
Clin Physiol Biochem. 1987;5(3-4):140-51.
8
The genetic basis of cancer.癌症的遗传基础。
J Singapore Paediatr Soc. 1992;34(3-4):126-35.
9
Detection of amplified oncogenes by differential polymerase chain reaction.通过差异聚合酶链反应检测扩增的癌基因。
Oncogene. 1989 Sep;4(9):1153-7.
10
Acquisition and loss of amplified genes: dramatic effects of hormones, tumor promoters and cytotoxic drugs.扩增基因的获得与丢失:激素、肿瘤启动子和细胞毒性药物的显著影响。
Princess Takamatsu Symp. 1983;14:235-54.

引用本文的文献

1
Insight on ecDNA-mediated tumorigenesis and drug resistance.关于染色体外DNA介导的肿瘤发生和耐药性的见解。
Heliyon. 2024 Mar 11;10(6):e27733. doi: 10.1016/j.heliyon.2024.e27733. eCollection 2024 Mar 30.
2
Selective entrapment of extrachromosomally amplified DNA by nuclear budding and micronucleation during S phase.在S期通过核出芽和微核形成对染色体外扩增DNA进行选择性捕获。
J Cell Biol. 1998 Mar 23;140(6):1307-20. doi: 10.1083/jcb.140.6.1307.
3
Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc.
通过减少染色体外扩增的c-myc诱导HL60细胞分化。
Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6674-8. doi: 10.1073/pnas.91.14.6674.